Damian Kołat
- Molecular Medicine top 10%
-
- Cancer-related molecular mechanisms research 4
- Biomaterials top 10%
-
- RNA modifications and cancer 8
- Ubiquitin and proteasome pathways 6
-
- Long-Term Effects of COVID-19 10
-
- COVID-19 Clinical Research Studies 7
-
- Genetics and Neurodevelopmental Disorders 7
-
- COVID-19 and Mental Health 4
-
- Nuclear Receptors and Signaling 4
- Co-authors
- Żaneta Kałuzińska‐KołatMateusz KciukRenata KontekAdrianna Gielecińskaİsmail Çeli̇kSomdutt MujwarElżbieta PłuciennikAndrzej K. Bednarek
- Partner nations
- PolandChinaUnited States
In The Last Decade
Damian Kołat
46 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 111
- Molecular Medicine 51
- Cancer Research 152
- Biomaterials 127
- Molecular Biology 553
- Oncology 208
Countries citing papers authored by Damian Kołat
This map shows the geographic impact of Damian Kołat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Damian Kołat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Damian Kołat more than expected).
Fields of papers citing papers by Damian Kołat
This network shows the impact of papers produced by Damian Kołat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Damian Kołat. The network helps show where Damian Kołat may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Damian Kołat, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 25 | |
| 6 | 2024 | 6 | |
| 7 | 2024 | 18 | |
| 8 | 2024 | 1 | |
| 9 | 2023 | 1 | |
| 10 | 2023 | 8 | |
| 11 | 2023 | 4 | |
| 12 | 2023 | 5 | |
| 13 | 2023 | 6 | |
| 14 | 2023 | 8 | |
| 15 | 2023 | 25 | |
| 16 | 2023 | 3 | |
| 17 | Doxorubicin—An Agent with Multiple Mechanisms of Anticancer Activitybreakdown → | 2023 | 385 |
| 18 | 2023 | 38 | |
| 19 | 2022 | 38 | |
| 20 | 2021 | 11 |
About Damian Kołat
Damian Kołat is a scholar working on Neurology, Molecular Medicine and Cancer Research, having authored 50 papers that have together received 1.1k indexed citations. Recurring topics across this work include Long-Term Effects of COVID-19 (10 papers), RNA modifications and cancer (8 papers), COVID-19 Clinical Research Studies (7 papers), Genetics and Neurodevelopmental Disorders (7 papers), Ubiquitin and proteasome pathways (6 papers), COVID-19 and Mental Health (4 papers), Cancer-related molecular mechanisms research (4 papers) and Nuclear Receptors and Signaling (4 papers). The work is most often cited by research in Molecular Medicine (51 citations), Cancer Research (152 citations) and Biomaterials (127 citations). Damian Kołat has collaborated with scholars based in Poland, China and United States. Frequent co-authors include Żaneta Kałuzińska‐Kołat, Mateusz Kciuk, Renata Kontek, Adrianna Gielecińska, İsmail Çeli̇k, Somdutt Mujwar, Elżbieta Płuciennik, Andrzej K. Bednarek, Lin-Yong Zhao and Lei Lei. Their work appears in journals such as Cells, Cancers, Molecules, Viruses and International Journal of Molecular Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.